Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Santi Suryani Chen"'
Autor:
Xing Liu, Meirong Wu, Huiyi Wang, Weiwei Yu, Hongyan Sun, Cunxiang Ju, Hongyu Wang, Zhiying Li, Mark Moore, Jing Zhou, Xiang Gao, Santi Suryani Chen
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Huiyi Wang, Cunxiang Ju, Mark Moore, Jun Xing, Jialu Fan, Huanhuan Hou, Santi Suryani Chen, Zhiying Li, Jing Zhao, Xiang Gao
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Shiying Guo, Cunxiang Ju, Hongyan Sun, Mingkun Zhang, Liyou Dong, Mengting Wang, Shuai Li, Dong Li, Huiyi Wang, Santi Suryani Chen, Zhiying Li, Mark Moore, Jing Zhao, Xiang Gao
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Xing Liu, Meirong Wu, Huiyi Wang, Weiwei Yu, Jianming Xu, Hongyan Sun, Cunxiang Ju, Hongyu Wang, Santi Suryani Chen, Zhiying Li, Mark Wade Moore, Jing Zhao, Xiang Gao
Publikováno v:
Cancer Research. 83:5198-5198
Introduction: GARP (Glycoprotein-A repetitions predominant) is a cell surface receptor which is coded by Lrrc32 (Leucine rich repeat containing protein 32) and involved in the activation of TGF-beta. The expression of GARP has been widely found in va
Autor:
Meirong Wu, Shiru Zhang, Fang Zhu, Hongyan Sun, Jianming Xu, Cunxiang Ju, Hongyu Wang, Santi Suryani Chen, Zhiying Li, Mark Wade Moore, Jing Zhao, Xiang Gao
Publikováno v:
Cancer Research. 83:4472-4472
Hematological malignancies, including leukemia, lymphoma and multiple myeloma, account for about 7% of all newly diagnosed cancers. Allogeneic hematopoietic stem cell transplantation (HSCT) is a traditional treatment for hematologic malignancies. Cur
Autor:
Shiying Guo, Lingyu Song, Xin Qin, Jianming Xu, Hongyan Sun, Cunxiang Ju, Hongyu Wang, Santi Suryani Chen, Zhiying Li, Mark Wade Moore, Jing Zhao, Xiang Gao
Publikováno v:
Cancer Research. 83:5199-5199
Immune checkpoint molecule B7-H3, also known as CD276, is a member of the B7-CD28 family of immunomodulatory proteins. It is a type I membrane protein with sequence similarities to the extracellular domain of programmed death-ligand 1 (PD-L1). B7-H3
Autor:
Huiyi Wang, Jialu Fan, Shiying Guo, Mingkun Zhang, Shuai Li, Santi Suryani Chen, Zhiying Li, Mark Wade Moore, Jing Zhao, Xiang Gao, Cunxiang Ju
Publikováno v:
Cancer Research. 83:5202-5202
Severe immunodeficient mice engrafted with human hematopoietic stem cells (HSC) have been extensively used in immuno-oncology related studies to evaluate the efficacy of cancer therapies. However, because of species differences, murine cytokines prov
Autor:
Fang Zhu, Hongyan Sun, Qian Lu, Yuan Fang, Jianming Xu, Cunxiang Ju, Hongyu Wang, Santi Suryani Chen, Zhiying Li, Mark Wade Moore, Jing Zhao, Xiang Gao
Publikováno v:
Cancer Research. 83:3242-3242
Antibody-drug conjugates (ADCs) are effective anti-tumor therapies with high specificity, with little toxicity and side effects. Xenograft tumor models based on immunodeficient mice have been used for evaluating the human anti-tumor efficacy of ADCs.
Autor:
Huiyi Wang, Jun Xing, Jialu Fan, Huanhuan Hou, Santi Suryani Chen, Zhiying Li, Mark Wade Moore, Jing Zhao, Xiang Gao, Cunxiang Ju
Publikováno v:
Cancer Research. 83:5192-5192
Human immune cell reconstitution (PBMC or CD34+ hematopoietic stem cell; HSC) is commonly performed in immunodeficient mouse strains such as NCG, NSG, or NOG. The use of PBMC is preferred for multiple reasons, including faster engraftment, lower cost
Autor:
Xiaoliu Yang, Yunlong Jiang, Xue Wu, Mingkun Zhang, Jing Zhao, Santi Suryani Chen, Zhiying Li, Erica Trujillo, Mark Wade Moore, Xiang Gao, Cunxiang Ju
Publikováno v:
Cancer Research. 83:5205-5205
In May 2021, the FDA approved sotorasib (Lumakras™) as the first treatment for adult patients with non-small cell lung cancer (NSCLC) harboring the KRASG12C genetic mutation. To study the relationship between the mutational activation of KRAS and t